Aspirin and Preeclampsia

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 180 participants.

Also called NCT04479072

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 180 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04479072
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04479072. Randomized; double masking; primary purpose prevention. Start 2021-02-15 (actual); primary completion 2026-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Aspirin and Preeclampsia
Condition
Preeclampsia Postpartum
Intervention (Drug)
Aspirin 81 mg
Intervention (Drug)
Placebo
Lead sponsor
University of Chicago (class: other)

Record details

Record id
cardio:ct-nct04479072
Content hash
b41435aa56ea6dd99a5cea02a18e2bff36783f7628322c933a7efdc33793afb4